Categories Analysis, Leisure & Entertainment

A look at Electronic Arts’ (EA) expectations for the near term

For the full year of 2025, net bookings are expected to range between $7.30-7.70 billion

Shares of Electronic Arts (NASDAQ: EA) stayed red on Friday. The stock has gained 6% over the past three months. The company saw its revenues decline during the fourth quarter of 2024 but it also delivered a profit for the period compared to a loss in the prior year.

In fiscal year 2025, EA plans to drive growth through new game releases, continued execution and growth in core live services, and strategic growth initiatives. Here’s a look at its expectations for the near term:

Revenue

Electronic Arts’ revenue declined 5% year-over-year to $1.78 billion in Q4 2024. For the first quarter of 2025, the company expects net revenues to range between $1.57-1.67 billion. For fiscal year 2025, net revenues are expected to be approx. $7.1-7.5 billion.

Electronics Arts Q4 2024 earnings infographic

Earnings

In the fourth quarter of 2024, EA delivered net income of $182 million, or $0.67 per share, compared to a loss of $12 million, or $0.04 per share, in the same period last year. In Q1 2025, net income is expected to be approx. $197-243 million and EPS is expected to be approx. $0.73-0.90. For FY2025, net income is expected to range between approx. $904 million to $1.08 billion while EPS is estimated to be $3.34-4.00.

Net bookings

In Q4 2024, net bookings fell 14% YoY to $1.67 billion. In Q1 2025, net bookings are expected to be approx. $1.15-1.25 billion. For the full year of 2025, net bookings are expected to range between $7.30-7.70 billion.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top